Michael Hewson, chief market analyst at CMC Markets UK, says: For a company that has been at the forefront of leading the fight against Covid-19 the performance in the AstraZeneca share price has been very underwhelming, with the shares at ten-month lows.
Don’t read the headline, read the content as well
As concerns grow over the protection offered by the Oxford AstraZeneca vaccine to E484K variants grows, the case for the government to prioritise a 2nd dose of an alternative vaccine becomes increasingly compelling
6-9 months? Sounds like time for the virus to have mutated further, which could make them less efficacious. 🤔
So the plan is that we all need to get vaccinated twice a year? Psychopaths 🤦🏻♀️🤦🏻♀️🤮🤮
Lately you seem to have become an advert for AstraZeneca. How puzzling!
Seems to take alot to raise AstraZeneca share price. They've saved the world! Price = +0.2% Gamestop with no money = +4000% .
The fact these companies are profiteering off this illness is pretty disgusting.
Much needed due to less efficacy against SA variant.COVID19